Patel Anish
CHIEF OPERATING OFFICER
Patel Anish has filed 6 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 17, 2026.
On the most recent filing, Patel Anish is listed as CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. Inside the rolling window, Patel Anish reported no open-market purchases and 3 open-market sales totaling $1.6M in ELVN. The largest disclosed transaction in the window is a sale of 48,300 ELVN shares on Jan 9, 2026, worth $1.4M.
Companies traded
Other insiders at ELVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Patel Anish made?
Patel Anish has filed 6 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Patel Anish trade?
Patel Anish has filed SEC Form 4 disclosures for 1 company, including ELVN.
When was Patel Anish's most recent SEC Form 4 filing?
Patel Anish's most recent SEC Form 4 filing on Tracefour is dated Feb 17, 2026.
What is Patel Anish's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Patel Anish is listed as CHIEF OPERATING OFFICER.
What is Patel Anish's total buy and sell value in the current window?
Inside the rolling retention window, Patel Anish bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Patel Anish's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 48,300 ELVN shares on 2026-01-09, worth $1.4M, per SEC Form 4 filings.